Prof. Kim founded AlgenDrug Co. Ltd for AI-based drug discovery

Prof. Kim founded AIgenDrug Co. Ltd that will deploy and service AI-based drug discovery tools in all major steps of drug development.

Prof. Kim assumed CEO of AIgenDrug on 2021. 7. 16. The first product on AI-based drug toxicity prediction is planned to launch in Spring 2022. See for more details.